StonvexLoading…
StonvexStonvexStonvexCore line items from CCK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $12.37B | $11.80B | $12.01B | $12.94B |
Operating Income | $1.55B | $1.42B | $1.27B | $1.34B |
Net Income | $738.00M | $424.00M | $450.00M | $727.00M |
EPS (Diluted) | $6.38 | $3.55 | $3.76 | $5.99 |
Total Assets | $14.27B | $13.85B | $15.03B | $14.30B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $764.00M | $918.00M | $1.31B | $550.00M |
Free Cash Flow OCF − CapEx | $1.12B | $789.00M | $660.00M | $-36.00M |
Shares Outstanding | 113.42M | 118.50M | 120.64M | 119.95M |